Cadila Healthcare Intends To Licence Phibro’s Poultry Vaccine

Both Zydus Cadila and Animal Health Corporation announced their willingness to come into a long term agreement for innovative poultry vaccine technology and want to know that how to a new vaccine manufacturing facility to be built by Zydus Cadila.
A swine, dairy, diversified global developer, manufacturing and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, beef cattle and aquaculture is by Phibro Animal Healthcare.
On NSE the share of Cadila Healthcare was trading higher at Rs 2.25/share at Rs 519.40/share, gains of 0.04% and has delivered 55% returns in a period of 1 year, has outperformed the BSE Sensex and BSE Healthcare indices over the same period.
185674 shares of combining NSE+BSE were traded on the counter and has Rs 52871.19cr of current market cap.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ – 0731-6626222 | Toll Free – 1800-3010-2007 ✔
Give a Missed Call for Free Trial – 09699997717 ✔
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s